RAPT Therapeutics Inc (RAPT)
4.03
-0.11
(-2.66%)
USD |
NASDAQ |
May 17, 16:00
4.03
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Shares Outstanding: 34.90M for March 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 31, 2024 | 34.90M |
March 28, 2024 | 34.80M |
March 04, 2024 | 34.80M |
December 31, 2023 | 34.40M |
November 07, 2023 | 34.40M |
September 30, 2023 | 34.36M |
August 03, 2023 | 34.36M |
June 30, 2023 | 34.35M |
May 05, 2023 | 34.34M |
March 31, 2023 | 34.29M |
March 30, 2023 | 34.29M |
March 08, 2023 | 34.29M |
December 31, 2022 | 34.25M |
November 22, 2022 | 33.96M |
November 04, 2022 | 29.91M |
September 30, 2022 | 29.89M |
August 04, 2022 | 29.66M |
June 30, 2022 | 29.65M |
June 16, 2022 | 29.65M |
May 06, 2022 | 29.64M |
March 31, 2022 | 29.59M |
March 28, 2022 | 29.59M |
March 04, 2022 | 29.57M |
December 31, 2021 | 29.56M |
November 08, 2021 | 29.55M |
Date | Value |
---|---|
September 30, 2021 | 29.51M |
August 06, 2021 | 29.49M |
June 30, 2021 | 29.48M |
June 18, 2021 | 29.37M |
May 04, 2021 | 25.01M |
April 05, 2021 | 24.87M |
March 31, 2021 | 24.86M |
March 04, 2021 | 24.87M |
January 15, 2021 | 24.84M |
December 31, 2020 | 24.77M |
November 10, 2020 | 24.56M |
September 30, 2020 | 24.50M |
August 07, 2020 | 24.47M |
June 30, 2020 | 24.44M |
May 07, 2020 | 24.37M |
April 23, 2020 | 24.33M |
March 31, 2020 | 24.33M |
March 20, 2020 | 24.33M |
February 11, 2020 | 24.33M |
December 31, 2019 | 21.83M |
December 06, 2019 | 21.83M |
November 04, 2019 | 21.28M |
October 31, 2019 | 21.28M |
October 28, 2019 | 21.28M |
August 01, 2019 | 21.28M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
21.28M
Minimum
Aug 01 2019
34.90M
Maximum
Mar 31 2024
28.36M
Average
29.51M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Emergent BioSolutions Inc | 52.40M |
Avinger Inc | 1.702M |
Tonix Pharmaceuticals Holding Corp | 95.54M |
Skye Bioscience Inc | 28.07M |
Axsome Therapeutics Inc | 47.50M |